University of Melbourne

University of Melbourne
#Financing #Radiopharmaceuticals #Spinout #Start-ups #University of Melbourne

Melbourne radiopharmaceuticals spinout launches with AUD$12 million

Australian radiopharmaceuticals spinout, Skopos Bio, has launched with an AUD$12 million (US$8.3 million) seed round, led by a global investor syndicate.  The company was founded by three clinical and translational scientists from Melbourne’s Peter MacCallum Cancer Centre (Peter Mac), who continue to treat patients and lead research:  Professor Michael Hofman… Read More

#Business & Investment #News #Start-up Zone

HIV cell
#HIV #Lipid based nanoparticle (LNP) #mRNA #University of Melbourne

New nanoparticle design inspires hopes of HIV cure

Researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne have demonstrated a way to make HIV visible, paving the way to a complete cure. In a paper published in Nature Communications, the scientists have shown for the first time that… Read More

#Editor's Choice #News